MarketPeel
Insider Trading Intelligence
Pricing
…
IE

Idan Elmelech

BBOT
COO & PRINCIPAL FINANCIAL OFCR · BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. · CIK 0002058437
FILING MIX · LIFETIME100%/0%
BUYS
1
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
May 2026
HOLDINGS NOW
758,222
AVG SELL PX
—
TRADE KIND
SHOWING 1 / 1
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Idan Elmelech. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 1 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
BBOT
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
758,222——758,222May 10, 2026May 12, 2026 ↗
Other insiders · BBOT
Loading peer insiders…
About this filer
CIK 0002058437
ROLE
COO & Principal Financial Ofcr
PRIMARY
BBOT
COMPANIES
1
ACTIVE SINCE
May 2026
MARKETPEEL · /INSIDER/0002058437DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback